NEW YORK (GenomeWeb News) – PerkinElmer said today that it has struck an assay development and sample testing collaboration with immunological reagents developer BioLegend.

The agreement will enable BioLegend to offer immunoassay development and bioanalytical testing based on PerkinElmer's AlphaLISA assay technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.